IART logo

Integra LifeSciences Holdings Corporation (IART)

Profile

Full Name

Integra LifeSciences Holdings Corporation

Ticker

NASDAQ: IART

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

August 16, 1995

Indexes

Not included

Website

https://www.integralife.com

Employees

4396

Key Details

Price

$15.38(+3.92%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.61B(+4.47% YoY)

Annual EPS

-$0.09(-110.71% YoY)

PE ratio

-

Next earnings date

Nov 3, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $15.38
    IART price is $15.38

    30-Day Relative Volume

    0.72
    IART 30-day relative volume is 0.72

    Price Performance

    Price Today change

    +3.92%
    IART price is up +3.92% today

    Price YTD change

    -32.19%
    IART price is down -32.19% since January 1st

    Price 1-year change

    -12.26%
    IART price is down -12.26% year-on-year

    Price 3-year change

    -66.23%
    IART price is down -66.23% over the past 3 years

    Price Range

    Price All-time high

    $77.40
    IART price is currently -80.13% below its historical high of $77.40

    Price 3-year low

    $11.06
    IART price is currently +39.06% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.20B
    IART market capitalization is $1.20 billion

    Market cap 3-year change

    -68.5%
    IART market capitalization is down -68.5% over the past 3 years

    Market cap All-time high

    $6.48B
    IART market capitalization is currently -81.51% below its historical high of $6.48 billion

    Market cap sector rank

    73.99%
    IART market capitalization is higher than 73.99% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.42%
    IART shares outstanding is up +0.42% year-on-year

    Shares Outstanding 3-Year Change

    -6.7%
    IART shares outstanding is down -6.7% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.17
    IART beta is 1.17

    200-day SMA

    $17.95
    IART price is currently -14.33% below its 200-day simple moving average

    50-day SMA

    $13.74
    IART price is currently +11.95% above its 50-day simple moving average

    RSI

    58.46
    IART 14-day relative strength index is 58.46

    Volume

    0.72
    IART 30-day relative volume is 0.72

    ATR

    $0.67
    IART average true range is $0.67

    10-day Historical Volatility

    31.78%
    IART 10-day historical volatility is 31.78%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.61B
    IART annual revenue is $1.61 billion

    Revenue Analysts estimate

    $1.67B
    IART annual revenue is currently -3.54% lower than the consensus analysts' forecast

    Revenue 1-year change

    +4.47%
    IART annual revenue is up +4.47% year-on-year

    Revenue Sector rank

    88.02%
    IART annual revenue is higher than 88.02% of companies in Healthcare sector

    EPS

    EPS

    -$0.09
    IART annual earnings per share is -$0.09

    EPS Analysts estimate

    $2.21
    IART annual earnings per share is currently -104.07% lower than the consensus analysts' forecast

    EPS 1-year change

    -110.71%
    IART annual earnings per share is down -110.71% year-on-year

    EPS Sector rank

    73.47%
    IART annual earnings per share is higher than 73.47% of companies in Healthcare sector

    Profit

    Gross profit

    $882.06M
    IART annual gross profit is $882.06 million

    Gross margin

    54.77%
    IART annual gross profit margin is 54.77%

    Operating profit

    $28.41M
    IART annual operating income is $28.41 million

    Operating margin

    1.76%
    IART annual operating profit margin is 1.76%

    Net income

    -$6.94M
    IART annual net profit is -$6.94 million

    Net margin

    -0.43%
    IART annual net profit margin is -0.43%

    Expenses

    Total expenses

    $1.58B
    IART annual total expenses is $1.58 billion

    Operating expenses

    $853.65M
    IART annual total operating expenses is $853.65 million

    Cost of goods sold

    $728.47M
    IART annual cost of goods sold is $728.47 million

    Selling, general & administrative expenses

    $716.98M
    IART annual SGA is $716.98 million

    Depreciation and amortization

    $140.89M
    IART annual depreciation & amortization is $140.89 million

    Interest expense

    $0.00
    IART annual interest expense is $0.00

    Income tax

    -$11.29M
    IART annual income tax is -$11.29 million

    EBIT & EBITDA

    EBIT

    $52.40M
    IART annual earnings before interest & taxes is $52.40 million

    EBITDA

    $193.29M
    IART annual EBITDA is $193.29 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $4.04B
    IART annual total assets is $4.04 billion

    Non current assets

    $2.96B
    IART annual long term assets is $2.96 billion

    Current assets

    $1.08B
    IART annual total current assets is $1.08 billion

    Cash and cash equivalents

    $246.38M
    IART annual cash & cash equivalents is $246.38 million

    Accounts receivable

    $272.37M
    IART annual accounts receivable is $272.37 million

    Inventory

    $429.09M
    IART annual inventory is $429.09 million

    Liabilities

    Total liabilities

    $2.49B
    IART annual total liabilities is $2.49 billion

    Long term liabilities

    $1.57B
    IART annual total long term liabilities is $1.57 billion

    Current liabilities

    $922.13M
    IART annual total current liabilities is $922.13 million

    Accounts payable

    $82.50M
    IART annual accounts payable is $82.50 million

    Debt

    Total debt

    $1.98B
    IART annual total debt is $1.98 billion

    Total debt 1-year change

    +18.01%
    IART annual total debt is up +18.01% year-on-year

    Long term debt

    $1.36B
    IART annual long term debt is $1.36 billion

    Short term debt

    $621.62M
    IART annual short term debt is $621.62 million

    Equity & Capital

    Shareholders equity

    $1.55B
    IART annual stockholders equity is $1.55 billion

    Book value

    $1.55B
    IART annual book value is $1.55 billion

    Retained earnings

    $939.91M
    IART annual retained earnings is $939.91 million

    Working capital

    $159.56M
    IART annual working capital is $159.56 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $129.38M
    IART annual cash flow from operations is $129.38 million

    Cash from operations 1-year change

    -7.55%
    IART annual cash flow from operations is down -7.55% year-on-year

    Cash from investing

    -$390.81M
    IART annual cash flow from investing activities is -$390.81 million

    Cash from investing 1-year change

    -314.97%
    IART annual cash flow from investing activities is down -314.97% year-on-year

    Cash from financing

    $237.86M
    IART annual cash flow from financing activities is $237.86 million

    Cash from financing 1-year change

    +203.45%
    IART annual cash flow from financing activities is up +203.45% year-on-year

    CAPEX

    CAPEX

    $114.37M
    IART annual capital expenditures is $114.37 million

    CAPEX 1-year change

    +71.05%
    IART annual capital expenditures is up +71.05% year-on-year

    Free Cash Flow

    Free cash flow

    $15.01M
    IART annual free cash flow is $15.01 million

    Free cash flow 1-year change

    -79.46%
    IART annual free cash flow is down -79.46% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    54.77%
    IART annual gross profit margin is 54.77%

    Operating margin

    1.76%
    IART annual operating profit margin is 1.76%

    Net margin

    -0.43%
    IART annual net profit margin is -0.43%

    ROA & ROE

    ROA

    -0.18%
    IART annual return on assets is -0.18%

    ROE

    -0.44%
    IART annual return on equity is -0.44%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    IART price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    IART price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.15
    IART price to book ratio is 1.15

    PB ratio Sector rank

    37.09%
    IART price to book ratio is higher than 37.09% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.74
    IART price to sales ratio is 0.74

    PS ratio Sector rank

    16.34%
    IART price to sales ratio is higher than 16.34% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $2.96B
    IART enterprise value is $2.96 billion

    Enterprise value Sector rank

    83.76%
    IART enterprise value is higher than 83.76% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -8.91
    IART EV/EBITDA is -8.91

    EV/EBITDA Sector rank

    15.52%
    IART EV/EBITDA is higher than 15.52% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.17
    IART annual current ratio is 1.17

    Quick ratio

    0.71
    IART annual quick ratio is 0.71

    Leverage

    Debt to equity

    1.17
    IART annual debt to equity ratio is 1.17

    Interest coverage ratio

    -
    IART annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    4
    IART piotroski f-score is 4

    Altman Z-Score

    1.10
    IART altman z-score is 1.10

    Analyst ratings

    Recent major analysts updates

    May 9, 25 JMP Securities
    Market Outperform
    May 6, 25 Wells Fargo
    Equal-Weight
    May 6, 25 JP Morgan
    Underweight
    Apr 11, 25 Truist Securities
    Hold
    Mar 31, 25 Argus Research
    Buy
    Feb 26, 25 Citizens Capital Markets
    Market Outperform
    Nov 5, 24 Citigroup
    Sell
    Oct 14, 24 Truist Securities
    Hold
    Oct 7, 24 BTIG
    Neutral
    Oct 7, 24 B of A Securities
    Underperform

    Institutional Ownership

    Screeners with IART included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Stocks recommended to hold
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    Stocks above analysts price target
    • What is the ticker symbol for Integra LifeSciences Holdings Corporation?
    • Does Integra LifeSciences Holdings Corporation pay dividends?
    • What sector is Integra LifeSciences Holdings Corporation in?
    • What industry is Integra LifeSciences Holdings Corporation in?
    • What country is Integra LifeSciences Holdings Corporation based in?
    • When did Integra LifeSciences Holdings Corporation go public?
    • Is Integra LifeSciences Holdings Corporation in the S&P 500?
    • Is Integra LifeSciences Holdings Corporation in the NASDAQ 100?
    • Is Integra LifeSciences Holdings Corporation in the Dow Jones?
    • When was Integra LifeSciences Holdings Corporation's last earnings report?
    • When does Integra LifeSciences Holdings Corporation report earnings?

    What is the ticker symbol for Integra LifeSciences Holdings Corporation?

    The ticker symbol for Integra LifeSciences Holdings Corporation is NASDAQ:IART

    Does Integra LifeSciences Holdings Corporation pay dividends?

    No, Integra LifeSciences Holdings Corporation does not pay dividends

    What sector is Integra LifeSciences Holdings Corporation in?

    Integra LifeSciences Holdings Corporation is in the Healthcare sector

    What industry is Integra LifeSciences Holdings Corporation in?

    Integra LifeSciences Holdings Corporation is in the Medical Devices industry

    What country is Integra LifeSciences Holdings Corporation based in?

    Integra LifeSciences Holdings Corporation is headquartered in United States

    When did Integra LifeSciences Holdings Corporation go public?

    Integra LifeSciences Holdings Corporation's initial public offering (IPO) was on August 16, 1995

    Is Integra LifeSciences Holdings Corporation in the S&P 500?

    No, Integra LifeSciences Holdings Corporation is not included in the S&P 500 index

    Is Integra LifeSciences Holdings Corporation in the NASDAQ 100?

    No, Integra LifeSciences Holdings Corporation is not included in the NASDAQ 100 index

    Is Integra LifeSciences Holdings Corporation in the Dow Jones?

    No, Integra LifeSciences Holdings Corporation is not included in the Dow Jones index

    When was Integra LifeSciences Holdings Corporation's last earnings report?

    Integra LifeSciences Holdings Corporation's most recent earnings report was on July 31, 2025

    When does Integra LifeSciences Holdings Corporation report earnings?

    The next expected earnings date for Integra LifeSciences Holdings Corporation is November 3, 2025
    On this page